Research for effect and mechanism of HanTangping VS Metformin treatment of newly diagnosed type 2 diabetes: : a randomized controlled trial

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•Those who meet the diagnostic criteria of Western medicine and the diagnostic criteria of TCM syndromesand:
•1. Aged 18 to 60 years;
•2. Diagnosed as type 2 diabetes, who had not received any hypoglycemic medication in the past and who had poor control of blood glucose after 3 months of dietary exercise or had short-term hypoglycemic medication (<1 month) and discontinued for more than 3 months.
•3. Islet function is acceptable, insulin release test shows delayed insulin secretion or insulin peak / basal value = 3 (Ip / Io = 3).
•4. 18kg/m2=BMI=35kg/m2.
•5. Voluntary participants in the study and signed informed consent.

•1. Although the blood glucose is higher than normal, the blood glucose test drops below the diagnostic value through the diet control and the increase in the activity during the test introduction phase.
•2. Pregnancy or lactation women.
•3. People who cannot take metformin.
•4. Those who are allergic to traditional Chinese medicine ingredients.
•5. People with serious heart, liver, kidney, brain and other complications or other serious primary diseases.
•6. People with acute metabolic disorders such as diabetic ketoacidosis or co-infection in the past 1 month.
•7. People who are unwilling to cooperate or mentally ill.
•8. People with diabetes complications as the main symptom

发起方

The First Affiliated Hospital of Guangzhou University of Chinese Medicine